Are PCSK9 inhibitors preferable to statins in patients with stroke risk?

A meta-analysis links statins to an increased risk of haemorrhagic stroke in a dose-dependent manner

Statins are associated with an increased risk of haemorrhagic stroke while PCSK9 inhibitors are not, say researchers who have pooled the evidence from randomised controlled trials.

Pills suggesting tatins and PCSK9 inhibitors

Although the absolute risk of haemorrhagic stroke with statins is low, the US investigators suggest PCSK9 inhibitors might be preferable for lipid lowering in patients at increased risk.

These include people with a history of TIA, ischaemic stroke or